BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38585261)

  • 1. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
    Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
    Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.
    Ghosh T; Nandi P; Ganguly N; Guha I; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Baral R; Bose A
    Stem Cell Res Ther; 2019 Sep; 10(1):296. PubMed ID: 31547863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of tumor microenvironment by neem leaf glycoprotein potentiates effector T cell functions and therapeutically intervenes in the growth of mouse sarcoma.
    Barik S; Banerjee S; Mallick A; Goswami KK; Roy S; Bose A; Baral R
    PLoS One; 2013; 8(6):e66501. PubMed ID: 23785504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent.
    Mallick A; Barik S; Ghosh S; Roy S; Sarkar K; Bose A; Baral R
    Immunotherapy; 2014; 6(7):821-31. PubMed ID: 25290415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neem leaf glycoprotein is superior than cisplatin and sunitinib malate in restricting melanoma growth by normalization of tumor microenvironment.
    Barik S; Bhuniya A; Banerjee S; Das A; Sarkar M; Paul T; Ghosh T; Ghosh S; Roy S; Pal S; Bose A; Baral R
    Int Immunopharmacol; 2013 Sep; 17(1):42-9. PubMed ID: 23747315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma.
    Mallick A; Barik S; Goswami KK; Banerjee S; Ghosh S; Sarkar K; Bose A; Baral R
    PLoS One; 2013; 8(1):e47434. PubMed ID: 23326300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.
    Ganguly N; Das T; Bhuniya A; Guha I; Chakravarti M; Dhar S; Sarkar A; Bera S; Dhar J; Dasgupta S; Saha A; Ghosh T; Das J; Sk UH; Banerjee S; Laskar S; Bose A; Baral R
    Cell Commun Signal; 2024 Apr; 22(1):237. PubMed ID: 38649988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neem leaf glycoprotein is nontoxic to physiological functions of Swiss mice and Sprague Dawley rats: histological, biochemical and immunological perspectives.
    Mallick A; Ghosh S; Banerjee S; Majumder S; Das A; Mondal B; Barik S; Goswami KK; Pal S; Laskar S; Sarkar K; Bose A; Baral R
    Int Immunopharmacol; 2013 Jan; 15(1):73-83. PubMed ID: 23178577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Chakraborty T; Pal S; Baral R
    J Immunother; 2009 Jan; 32(1):42-53. PubMed ID: 19307993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neem leaf glycoprotein prevents post-surgical sarcoma recurrence in Swiss mice by differentially regulating cytotoxic T and myeloid-derived suppressor cells.
    Sarkar M; Ghosh S; Bhuniya A; Ghosh T; Guha I; Barik S; Biswas J; Bose A; Baral R
    PLoS One; 2017; 12(4):e0175540. PubMed ID: 28414726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.
    Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Biswas J; Mallick A; Bose A; Baral R
    Immunol Lett; 2016 Jul; 175():31-9. PubMed ID: 27178306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neem leaf glycoprotein promotes dual generation of central and effector memory CD8(+) T cells against sarcoma antigen vaccine to induce protective anti-tumor immunity.
    Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Saha A; Dasgupta S; Barik S; Bose A; Baral R
    Mol Immunol; 2016 Mar; 71():42-53. PubMed ID: 26851529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neem leaf glycoprotein salvages T cell functions from Myeloid-derived suppressor cells-suppression by altering IL-10/STAT3 axis in melanoma tumor microenvironment.
    Sarkar M; Bhuniya A; Ghosh S; Sarkar A; Saha A; Dasgupta S; Bera S; Chakravarti M; Dhar S; Guha I; Ganguly N; Das T; Banerjee S; Pal S; Ghosh SK; Bose A; Baral R
    Melanoma Res; 2021 Apr; 31(2):130-139. PubMed ID: 33625102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neem leaf glycoprotein reverses tumor-induced and age-associated thymic involution to maintain peripheral CD8
    Guha I; Bhuniya A; Nandi P; Dasgupta S; Sarkar A; Saha A; Das J; Ganguly N; Ghosh S; Ghosh T; Sarkar M; Ghosh S; Majumdar S; Baral R; Bose A
    Immunotherapy; 2020 Aug; 12(11):799-818. PubMed ID: 32698648
    [No Abstract]   [Full Text] [Related]  

  • 16. Neem leaf glycoprotein suppresses regulatory T cell mediated suppression of monocyte/macrophage functions.
    Chakraborty T; Bose A; Goswami KK; Goswami S; Chakraborty K; Baral R
    Int Immunopharmacol; 2012 Feb; 12(2):326-33. PubMed ID: 22210373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neem leaf glycoprotein regulates function of tumor associated M2 macrophages in hypoxic tumor core: Critical role of IL-10/STAT3 signaling.
    Goswami KK; Sarkar M; Ghosh S; Saha A; Ghosh T; Guha I; Barik S; Banerjee S; Roy S; Bose A; Dasgupta P; Baral R
    Mol Immunol; 2016 Dec; 80():1-10. PubMed ID: 27776244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neem leaf glycoprotein directs T-bet-associated type 1 immune commitment.
    Bose A; Chakraborty K; Sarkar K; Goswami S; Haque E; Chakraborty T; Ghosh D; Roy S; Laskar S; Baral R
    Hum Immunol; 2009 Jan; 70(1):6-15. PubMed ID: 18983881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity.
    Chakraborty K; Bose A; Chakraborty T; Sarkar K; Goswami S; Pal S; Baral R
    Cell Mol Immunol; 2010 Sep; 7(5):396-408. PubMed ID: 20622890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.